117 related articles for article (PubMed ID: 27062362)
1. Glucose Levels Before the Onset of Asparaginase Predicts Transient Hyperglycemia in Children With Acute Lymphoblastic Leukemia.
Gatzioura I; Papakonstantinou E; Dimitriadou M; Kourti M; Sidi V; Triantafyllou P; Koliouskas D; Christoforidis A
Pediatr Blood Cancer; 2016 Jul; 63(7):1181-4. PubMed ID: 27062362
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia.
Lowas SR; Marks D; Malempati S
Pediatr Blood Cancer; 2009 Jul; 52(7):814-8. PubMed ID: 19260096
[TBL] [Abstract][Full Text] [Related]
3. Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.
Yoshida H; Imamura T; Saito AM; Takahashi Y; Suenobu S; Hasegawa D; Deguchi T; Hashii Y; Kawasaki H; Endo M; Hori H; Suzuki N; Kosaka Y; Kato K; Yumura-Yagi K; Hara J; Oda M; Sato A; Horibe K;
PLoS One; 2015; 10(8):e0136428. PubMed ID: 26317422
[TBL] [Abstract][Full Text] [Related]
4. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
[TBL] [Abstract][Full Text] [Related]
5. L-asparaginase-induced abnormality in plasma glucose level in patients of acute lymphoblastic leukemia admitted to a tertiary care hospital of Odisha.
Panigrahi M; Swain TR; Jena RK; Panigrahi A
Indian J Pharmacol; 2016; 48(5):595-598. PubMed ID: 27721550
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration.
Pollock NI; Flamand Y; Zhu J; Millington K; Stevenson K; Silverman LB; Vrooman LM; Cohen LE
Pediatr Blood Cancer; 2022 Jul; 69(7):e29505. PubMed ID: 34931744
[TBL] [Abstract][Full Text] [Related]
7. L-asparaginase related hyperglycemia.
Iyer RS; Rao SR; Pai S; Advani SH; Magrath IT
Indian J Cancer; 1993 Jun; 30(2):72-6. PubMed ID: 8225380
[TBL] [Abstract][Full Text] [Related]
8. Reply to comment on: Glucose levels before the onset of asparaginase predicts transient hyperglycemia in children with acute lymphoblastic leukemia.
Christoforidis A
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28695997
[No Abstract] [Full Text] [Related]
9. Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
.
Thu Huynh V; Bergeron S
Clin J Oncol Nurs; 2017 Oct; 21(5):E248-E259. PubMed ID: 28945721
[TBL] [Abstract][Full Text] [Related]
10. [Hyperglycemia as a side effect of using L-asparaginase in children with acute lymphoblastic leukemia (ALL].
Brodkiewicz A; Kamieńska E; Urasiński T; Peregud-Pogorzelski J
Acta Haematol Pol; 1995; 26(1):99-101. PubMed ID: 7747569
[TBL] [Abstract][Full Text] [Related]
11. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
[TBL] [Abstract][Full Text] [Related]
12. Transient hyperglycemia during childhood acute lymphocytic leukemia chemotherapy: an old event revisited.
Spinola-Castro AM; Siviero-Miachon AA; Andreoni S; Tosta-Hernandez PD; Macedo CR; Lee ML
Clin Adv Hematol Oncol; 2009 Jul; 7(7):465-72. PubMed ID: 19701154
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia induced by chemotherapeutic agents used in acute lymphoblastic leukemia: report of three cases.
Wang YJ; Chu HY; Shu SG; Chi CS
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jun; 51(6):457-61. PubMed ID: 8281494
[TBL] [Abstract][Full Text] [Related]
14. Cerebral thrombotic complications in adolescent leukemia/lymphoma patients treated with L-asparaginase-containing chemotherapy.
Imamura T; Morimoto A; Kato R; Izumi M; Murakami A; Matuo S; Kiyosawa N; Kano G; Yoshioka H; Sugimoto T; Imashuku S
Leuk Lymphoma; 2005 May; 46(5):729-35. PubMed ID: 16019511
[TBL] [Abstract][Full Text] [Related]
15. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
[TBL] [Abstract][Full Text] [Related]
16. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone.
Pui CH; Burghen GA; Bowman WP; Aur RJ
J Pediatr; 1981 Jul; 99(1):46-50. PubMed ID: 6454771
[TBL] [Abstract][Full Text] [Related]
18. Hypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents.
Persson L; Harila-Saari A; Hed Myrberg I; Heyman M; Nilsson A; Ranta S
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28440015
[TBL] [Abstract][Full Text] [Related]
19. [The adverse reaction of L-asparaginase and its prevention].
Lai YH; Wu ZL; Chen FX
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):533-4. PubMed ID: 16083559
[No Abstract] [Full Text] [Related]
20. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia.
Cetin M; Yetgin S; Kara A; Tuncer AM; Günay M; Gümrük F; Gürgey A
J Med; 1994; 25(3-4):219-29. PubMed ID: 7996065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]